{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:56Z","timestamp":1792806056000,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1124\/jpet.117.247049","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T18:45:15Z","timestamp":1520966715000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats"],"prefix":"10.1016","volume":"365","author":[{"given":"Michael D.","family":"Raleigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Laudenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Baruffaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela J.","family":"Roslawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela K.","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ivy","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Pentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.117.247049_bib1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1124\/jpet.117.247049_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ADA-120029870","article-title":"Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders","volume":"30","author":"Appel","year":"2004","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1124\/jpet.117.247049_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00952990.2016.1167215","article-title":"Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users","volume":"42","author":"Backonja","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1124\/jpet.117.247049_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.2042-7158.1997.tb06795.x","article-title":"Pharmacokinetics of heterologous and homologous immunoglobulin G, F(ab\u2032)2 and Fab after intravenous administration in the rat","volume":"49","author":"Bazin-Redureau","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.117.247049_bib5","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1124\/jpet.117.247049_bib6","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1124\/jpet.117.247049_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1440-1681.2007.04821.x","article-title":"Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat","volume":"35","author":"Chan","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.117.247049_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130050956","article-title":"Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans","volume":"143","author":"Comer","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.117.247049_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.2017.9308","article-title":"Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000\u20132015","volume":"318","author":"Dowell","year":"2017","journal-title":"JAMA"},{"key":"10.1124\/jpet.117.247049_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","article-title":"Effect of a nicotine vaccine on nicotine binding to \u03b22*-nicotinic acetylcholine receptors in vivo in human tobacco smokers","volume":"170","author":"Esterlis","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.117.247049_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bph.12305","article-title":"Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats","volume":"170","author":"Gott\u00e5s","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.117.247049_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/jcph.235","article-title":"Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users","volume":"54","author":"Harris","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.117.247049_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.117.247049_bib14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s11095-005-6154-y","article-title":"Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague\u2013Dawley rats: influence of streptozotocin-induced diabetes","volume":"22","author":"Huang","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.117.247049_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers","volume":"26","author":"Jalah","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1124\/jpet.117.247049_bib16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1521-0391.2011.00120.x","article-title":"Oxycodone abuse in New York city: characteristics of intravenous and intranasal users","volume":"20","author":"Jones","year":"2011","journal-title":"Am J Addict"},{"key":"10.1124\/jpet.117.247049_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2012.10.033","article-title":"Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats","volume":"74","author":"Jones","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/jpet.117.247049_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.117.247049_bib19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.intimp.2008.07.001","article-title":"Enhanced immunogenicity of a bivalent nicotine vaccine","volume":"8","author":"Keyler","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/jpet.117.247049_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.6b00977","article-title":"An advance in prescription opioid vaccines: overdose mortality reduction and extraordinary alteration of drug half-life","volume":"12","author":"Kimishima","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1124\/jpet.117.247049_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.117.247049_bib22","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.1500385","article-title":"The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse","volume":"194","author":"Laudenbach","year":"2015","journal-title":"J Immunol"},{"key":"10.1124\/jpet.117.247049_bib23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.117.247049_bib24","doi-asserted-by":"crossref","first-page":"pyu093","DOI":"10.1093\/ijnp\/pyu093","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","volume":"18","author":"Li","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.117.247049_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.117.247049_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.7352279","article-title":"Buprenorphine suppresses heroin use by heroin addicts","volume":"207","author":"Mello","year":"1980","journal-title":"Science"},{"key":"10.1124\/jpet.117.247049_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-3565(25)32374-8","article-title":"Operant analysis of human heroin self-administration and the effects of naltrexone","volume":"216","author":"Mello","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.247049_bib28","unstructured":"National Survey on Drug Use and Health (2014) Results from the 2013 National Survey on Drug Use and Health: detailed tables."},{"key":"10.1124\/jpet.117.247049_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1465-3362.2009.00100.x","article-title":"The Andalusian trial on heroin-assisted treatment: a 2 year follow-up","volume":"29","author":"Oviedo-Joekes","year":"2010","journal-title":"Drug Alcohol Rev"},{"key":"10.1124\/jpet.117.247049_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","article-title":"Prescription drug overdoses: a review","volume":"43","author":"Paulozzi","year":"2012","journal-title":"J Safety Res"},{"key":"10.1124\/jpet.117.247049_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2125.1992.tb04090.x","article-title":"The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects","volume":"33","author":"P\u00f6yhi\u00e4","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.117.247049_bib32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bcp.2011.11.004","article-title":"Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities","volume":"83","author":"Pravetoni","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.117.247049_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.247049_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.117.247049_bib35","doi-asserted-by":"crossref","first-page":"e101807","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247049_bib36","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"10.1124\/jpet.117.247049_bib37","doi-asserted-by":"crossref","first-page":"e96547","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247049_bib38","doi-asserted-by":"crossref","first-page":"e115696","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247049_bib39","doi-asserted-by":"crossref","first-page":"e0184876","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/jpet.117.247049_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.247049_bib41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1067\/mcp.2001.117981","article-title":"Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics","volume":"70","author":"Rentsch","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.117.247049_bib42","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.107.135111","article-title":"Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats","volume":"325","author":"Roiko","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.117.247049_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/0893-164X.17.3.203","article-title":"Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies","volume":"17","author":"Rosenberg","year":"2003","journal-title":"Psychol Addict Behav"},{"key":"10.1124\/jpet.117.247049_bib44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.117.247049_bib45","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.117.247049_bib46","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.117.247049_bib47","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(10)60349-2","article-title":"Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial","volume":"375","author":"Strang","year":"2010","journal-title":"Lancet"},{"key":"10.1124\/jpet.117.247049_bib48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00216-015-9223-z","article-title":"A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse","volume":"408","author":"Torres","year":"2016","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/jpet.117.247049_bib49","unstructured":"United Nations Office on Drugs and Crime (2016) World drug report 2016."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524267616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.117.247049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:03:51Z","timestamp":1739995431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524267616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0022356524267616"],"URL":"https:\/\/doi.org\/10.1124\/jpet.117.247049","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.117.247049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}